UNSPSC 51373404: Acetaminophen/codeine/guaifenesin/phenylpropanolamine
Commodity
Code facts
- Part of
-
-
51000000
-
51370000
- 51373400
-
51370000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51373404
Definition
This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.
The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.
Read the full definition
The European Medicines Agency schedules Acetaminophen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09611MIG. The World Health Organization schedules acetaminophen in its Anatomical Therapeutic Chemical (ATC) Classification.
The second component of this combination drug is an opiate with the molecular formula C18H21NO3.H2O, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier Q830PW7520, chemically known as codeine, sulfate but more generally known as codeine, which bears U.S. National Institutes of Health Compound Identifier 223652. The European Medicines Agency schedules Codeine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13424MIG.
The World Health Organization schedules codeine in its Anatomical Therapeutic Chemical (ATC) Classification. The third component of this combination drug is an expectorant with the molecular formula C10H14O4, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 495W7451VQ, chemically known as 1,2,3-propanetriol, ether with 2-methoxyphenol but more generally known as guaifenesin, which bears U.S. National Institutes of Health Compound Identifier 3516.
The European Medicines Agency schedules Guaifenesin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07973MIG. The term GUAIFENESIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 25, No. 10 1971, List 11). The World Health Organization schedules guaifenesin in its Anatomical Therapeutic Chemical (ATC) Classification.
The fourth component of this combination drug is an adrenergic agonist with the molecular formula C9H13NO, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 33RU150WUN, chemically known as 1r,2s-(-)-norephedrine hydrochloride but more generally known as phenylpropanolamine, which bears U.S. National Institutes of Health Compound Identifier 4786. The European Medicines Agency schedules Phenylpropanolamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09790MIG.
The term PHENYLPROPANOLAMINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 3, No. 3, 1989, List 29). The World Health Organization schedules phenylpropanolamine in its Anatomical Therapeutic Chemical (ATC) Classification.
About UNSPSC 51373404
UNSPSC 51373404 Acetaminophen/codeine/guaifenesin/phenylpropanolamine, a Commodity code, shows minimal alignment between the code's nominal scope and actual state and local procurement activity. Recent solicitations posted under this code do not request acetaminophen-codeine combination products; instead, they solicit parenteral pharmaceutical products (intravenous solutions and parenteral nutrition bags) and emergency-response medical supplies (naloxone and drug deactivation systems). The mismatch suggests the code is being applied inconsistently or does not reflect the pharmaceutical product lines state and local buyers are actually sourcing through this taxonomy.
The two recent opportunities come from different issuing-body types and geographies. The Washington State Department of Corrections posted RFQQ RFQQK13020 in September 2026 (due October 7, 2026) for parenteral products, services, and equipment to supply eight correctional facilities across three regions of Washington state, with DOC anticipating multiple contractor awards and an initial contract term through June 30, 2030. Seminole County, Florida posted IFB 60459723LAS in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, though the cited response date (July 26, 2023) appears to be a historical reference within the 2026 posting. State and local procurement activity under this code appears scattered and sparse, with no identifiable pattern of repeat buyers or concentrated geographic activity in recent months.
Quick answers
What is UNSPSC 51373404?
UNSPSC 51373404 is Acetaminophen/
Which NIGP codes match UNSPSC 51373404?
UNSPSC 51373404 maps to 1 NIGP code, 26948 Expectorants, Antitussives, and Mucolytic Agents.
On GovTribe
See everything under UNSPSC 51373404
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code